Authors
Latest:
Biosimilars: why deep discounts may become the dominant paradigmEuropean experience to date indicates a changing perspective on biosimilar pricing
Latest:
Rethinking Sample DistributionAs the number of specific services associated with sample distribution has grown, so has the number of service providers a manufacturer might use. It’s time to think about consolidating these services
Latest:
Oncology Networks Offer Distribution AlternativesThe recent acquisition of US Oncology by McKesson highlights the rising importance of the distributor-led networks
Latest:
Maintaining your digital marketing assetsPromotional content produced for, or derived from, digital media presents its own management and compliance complexities
Latest:
Specialty pharmaceuticals demand integrated patient and prescriber approachesTrue 'market access' should involve coordinated approaches to patients and their healthcare providers
Latest:
Dealing with biologics production uncertaintyThe biologics development and approval process for pharmaceutical companies around the world is typically long and complex, which increases the risk of inaccurately forecasting demand
Latest:
OPINION: Will Class-Wide REMS Programs Delay New Opioid Approvals?Class-wide opioid REMS will affect four million patients and require cooperation of more than 25 drug manufacturers
Latest:
Managing quality risks across the pharmaceutical supply chainWell designed quality systems follow the product life cycle and foster a culture of quality
Latest:
Evidence Generation Is the Foundation to Optimal Product PositioningEvidence Generation Is the Foundation to Optimal Product Positioning
Latest:
Collaboration key to a healthy supply chain in 2016HDMA seeks to encourage more outreach to business partners and government
Latest:
First physicians, now patients: Risk avoidance in patient support programsA look into the growing compliance risks associated with patient services
Latest:
Six Essentials for the Next-Generation Sampling PlatformNew technological capabilities will enable management of sample-distribution processes to keep up with a challenging environment
Latest:
The growing role of clinical trial educatorsAddressing patient recruitment and retention issues is a natural role for CTEs
Latest:
Industry Revenue Management Practices Are Showing Gradual ImprovementThe 7th Annual Model N survey shows that industry is struggling with the growing complexity of contracts and pricing for managed care and government programs
Latest:
AstraZeneca's Principles for Product-Related Online CommunicationsIndustry anticipates meaningful guidance from FDA on use of social media
Latest:
Getting Value From End-of-Life-Cycle PharmaceuticalsA review of 84 branded pharmaceutical products with changed ownership as of 2005 shows that many of them can continue to sell, often with much higher prices By Albert I. Wertheimer, PhD, MBA, Temple University, and Ellen F. Loh, BS, MBA, University of Maryland, Baltimore
Latest:
A growing preference for ready-to-administer vaccines: new guidelines, evidence, and trendsVaccine administration is shifting from multidose vials to prefilled syringes for a host of important safety and economic considerations
Latest:
Managing third-party risks in the life sciences industryInternal compliance reviews are not enough; life sciences companies need to assess their third-party business partners
Latest:
A Big Data approach to patient engagement and adherenceCombining high-quality patient-support services with comprehensive and continually updated analytics results in better outcomes
